Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

Wegovy vs Retatrutide

Editorial comparison of Wegovy (semaglutide) and Retatrutide (retatrutide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.

Side-by-side

DimensionWegovyRetatrutide
Generic namesemaglutideretatrutide
ManufacturerNovo NordiskEli Lilly
FDA approved2021
MechanismSemaglutide mimics GLP-1, a gut hormone released after meals.Where semaglutide hits one receptor and tirzepatide two, retatrutide adds a third: the glucagon receptor.
DosingTitrated over 4-5 months: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, increasing every 4 weeks.Investigational. Trial dosing is once-weekly subcutaneous injection with gradual titration; final approved doses are not set.
CostList price ~$1,350/month without insurance.No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product.
Pivotal trial result14.9% mean body-weight reduction at 68 weeks~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2)

Full Wegovy review →

Once-weekly injectable semaglutide for chronic weight management. ~15% body weight loss in trials.

Full Retatrutide review →

Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.

Frequently asked

Is Wegovy or Retatrutide more effective?+

In their pivotal trials, Wegovy reported 14.9% mean body-weight reduction at 68 weeks, while Retatrutide reported ~24% mean body-weight reduction at 48 weeks (highest dose, Phase 2). Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Wegovy and Retatrutide compare on cost?+

Wegovy: List price ~$1,350/month without insurance. With Novo Nordisk's patient assistance program, eligible self-pay patients can access at $200-500/month. Insurance coverage is patchy and often requires prior authorization plus a documented weight-related comorbidity. Retatrutide: No commercial price exists. Available only via clinical-trial enrollment. Beware any website selling 'retatrutide' today, it is not a legal product. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Wegovy to Retatrutide?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Wegovy and Retatrutide the same drug?+

No. Wegovy (semaglutide) and Retatrutide (retatrutide) are distinct medications from Novo Nordisk and Eli Lilly respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.

We may earn a commission when you click links to partners. Affiliate disclosure.